Insider trades
Wildon Farwell, Chief Officer of Dyne Therapeutics DYN, has filed 0 purchases and 18 sales on the open market. The latest trade was on 24/08/19.
Wildon Farwell
Chief Medical Officer
- Company
- Dyne Therapeutics DYN
- First filing
- 23/03/15
- Trades
- 20 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- No record
- Last trade
- 24/08/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DYN | Open-market sale10b5-1 plan | 24/08/19 | 24/08/20 | 2,321 sh2 trades | $45.12avg. | $104,726.6 | −1.6% |
DYN | Open-market sale10b5-1 plan | 24/06/11 | 24/06/11 | 2,636 sh2 trades | $31.27avg. | $82,427.72 | −1.8% |
DYN | Open-market sale10b5-1 plan | 24/05/16 | 24/05/17 | 2,381 sh2 trades | $28.27avg. | $67,309.95 | −1.6% |
DYN | Open-market sale10b5-1 plan | 24/03/11–24/03/12 | 24/03/12 | 2,615 sh2 trades | $25.65avg. | $67,081.9 | −1.7% |
DYN | Open-market sale10b5-1 plan | 24/03/07 | 24/03/11 | 9,921 sh2 trades | $25.86avg. | $256,584.6 | −6.1% |
| Open-market sale10b5-1 plan | 24/02/28 | 24/02/28 | 407 sh | $25.00 | $10,175 | −0.2% | |
| Open-market sale10b5-1 plan | 24/02/12 | 24/02/14 | 5,493 sh | $25.07 | $137,709.51 | −3.3% | |
| Open-market sale10b5-1 plan | 24/01/26 | 24/01/26 | 100 sh | $25.00 | $2,500 | −0.1% | |
DYN | Open-market sale10b5-1 plan | 23/12/11–23/12/12 | 23/12/12 | 2,666 sh2 trades | $10.66avg. | $28,413.26 | −1.6% |
| Open-market sale | 23/09/12 | 23/09/13 | 1,707 sh | $10.41 | $17,769.87 | −1.9% | |
| Open-market sale | 23/06/13 | 23/06/14 | 1,698 sh | $12.43 | $21,106.14 | −1.8% | |
| Open-market sale | 23/03/14 | 23/03/15 | 7,441 sh | $13.33 | $99,188.53 | −7.4% |